Risk factors of osteonecrosis of the jaw in patients with multiple myeloma receiving IV bisphosphonates
- Conditions
- Patients diagnosed with multiple myeloma and had received intravenous bisphosphonates.Risk factor, Multiple myeloma, Intravenous bisphosphonate
- Registration Number
- TCTR20230206007
- Lead Sponsor
- Chulalongkorn University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- nknown
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
1.Patients diagnosed with multiple myeloma received intravenous bisphosphonates.
2.Patients who evaluate and/or treated as a new case or relapse of multiple myeloma.
Exclusion Criteria
1.Patients had a history of radiation therapy to the jaws or of tumors or cysts.
2.Undergoing a radiation therapy in the head and neck region
3.Patients had a history of osteonecrosis of the jaw before treating multiple myeloma with IV bisphosphonate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Osteonecrosis of the jaw Time between beginning of IV bisphosphonate to the date diagnosed osteonecrosis of the jaw ICD 10
- Secondary Outcome Measures
Name Time Method /A N/A N/A